Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ruonan Xu

Showing results (91-100 of 101) with videos related to

Pageof 11
Sort By:
Ebiomedicine|December 28, 2021
Human mesenchymal stem cells treatment for severe COVID-19: 1-year follow-up results of a randomized, double-blind, placebo-controlled trialLei Shi, Xin Yuan, Weiqi Yao, et al.
Signal Transduction and Targeted Therapy|May 7, 2021
HLA-mismatched allogeneic adoptive immune therapy in severely immunosuppressed AIDS patientsRuonan Xu, Ji-Yuan Zhang, Bo Tu, et al.
Signal Transduction and Targeted Therapy|August 29, 2020
Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trialFanping Meng, Ruonan Xu, Siyu Wang, et al.
Cancer Medicine|June 3, 2024
Omicron neutralization character in patients with breast cancer and liver cancer after the nationwide omicron outbreakShaohua Zhang, Lili Tang, Chunmei Bao, et al.
Hepatology International|March 28, 2023
Metabolic interventions improve HBV envelope-specific T-cell responses in patients with chronic hepatitis BYu-Long Fu, Shuang-Nan Zhou, Wei Hu, et al.
Emerging Microbes & Infections|June 27, 2024
HLA-mismatched allogeneic adoptive immune therapy in patients with severely immunosuppressed AIDS: a multicenter, open-label, controlled, phase 2a studyTao Yang, Zhiman Xie, Zhe Xu, et al.
Hepatology International|April 15, 2026
Phase-specific polarization of peripheral helper T cells influences immunopathology and viral control in HBV infectionXiao-Yu Li, Peng Zhang, Mengmeng Zhu, et al.
Hepatology International|September 15, 2022
Reduction of natural killer cells is associated with poor outcomes in patients with hepatitis B virus-related acute-on-chronic liver failureHua-Jie Li, Ning Yang, Xiuying Mu, et al.
Communications Biology|July 7, 2023
Elevated glutamate impedes anti-HIV-1 CD8 + T cell responses in HIV-1-infected individuals on antiretroviral therapyYou-Yuan Wang, Cheng Zhen, Wei Hu, et al.
Nature Communications|February 15, 2024
Adipocyte p53 coordinates the response to intermittent fasting by regulating adipose tissue immune cell landscapeIsabel Reinisch, Helene Michenthaler, Alba Sulaj, et al.
Pageof 11

Showing results (91-100 of 101) with videos related to

Sort By:
Pageof 11
Ebiomedicine|December 28, 2021
Human mesenchymal stem cells treatment for severe COVID-19: 1-year follow-up results of a randomized, double-blind, placebo-controlled trialLei Shi, Xin Yuan, Weiqi Yao, et al.
Signal Transduction and Targeted Therapy|May 7, 2021
HLA-mismatched allogeneic adoptive immune therapy in severely immunosuppressed AIDS patientsRuonan Xu, Ji-Yuan Zhang, Bo Tu, et al.
Signal Transduction and Targeted Therapy|August 29, 2020
Human umbilical cord-derived mesenchymal stem cell therapy in patients with COVID-19: a phase 1 clinical trialFanping Meng, Ruonan Xu, Siyu Wang, et al.
Cancer Medicine|June 3, 2024
Omicron neutralization character in patients with breast cancer and liver cancer after the nationwide omicron outbreakShaohua Zhang, Lili Tang, Chunmei Bao, et al.
Hepatology International|March 28, 2023
Metabolic interventions improve HBV envelope-specific T-cell responses in patients with chronic hepatitis BYu-Long Fu, Shuang-Nan Zhou, Wei Hu, et al.
Emerging Microbes & Infections|June 27, 2024
HLA-mismatched allogeneic adoptive immune therapy in patients with severely immunosuppressed AIDS: a multicenter, open-label, controlled, phase 2a studyTao Yang, Zhiman Xie, Zhe Xu, et al.
Hepatology International|April 15, 2026
Phase-specific polarization of peripheral helper T cells influences immunopathology and viral control in HBV infectionXiao-Yu Li, Peng Zhang, Mengmeng Zhu, et al.
Hepatology International|September 15, 2022
Reduction of natural killer cells is associated with poor outcomes in patients with hepatitis B virus-related acute-on-chronic liver failureHua-Jie Li, Ning Yang, Xiuying Mu, et al.
Communications Biology|July 7, 2023
Elevated glutamate impedes anti-HIV-1 CD8 + T cell responses in HIV-1-infected individuals on antiretroviral therapyYou-Yuan Wang, Cheng Zhen, Wei Hu, et al.
Nature Communications|February 15, 2024
Adipocyte p53 coordinates the response to intermittent fasting by regulating adipose tissue immune cell landscapeIsabel Reinisch, Helene Michenthaler, Alba Sulaj, et al.
Pageof 11